Company Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse 04:01:04 2024-03-18 pm EDT 5-day change 1st Jan Change
121.4 USD -0.07% Intraday chart for Merck & Co., Inc. -1.08% +11.39%

Business Summary

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:

- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;

- sale of vaccines (18%);

- sale of animal health products (9.4%);

- other (2.9%).

Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).

Number of employees: 71,000

Sales per Business

USD in Million2022Weight2023Weight Delta
Pharmaceutical
89.1 %
52,005 87.7 % 53,583 89.1 % +3.03%
Animal Health
9.4 %
5,550 9.4 % 5,625 9.4 % +1.35%
Other
1.5 %
1,728 2.9 % 907 1.5 % -47.51%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
47.4 %
27,206 45.9 % 28,480 47.4 % +4.68%
Europe, Middle East and Africa
22.0 %
14,493 24.4 % 13,254 22.0 % -8.55%
China
11.3 %
5,191 8.8 % 6,802 11.3 % +31.03%
Asia Pacific
5.4 %
3,614 6.1 % 3,225 5.4 % -10.76%
Japan
5.3 %
3,629 6.1 % 3,164 5.3 % -12.81%
Latin America
5.1 %
2,582 4.4 % 3,086 5.1 % +19.52%
Other
3.5 %
2,568 4.3 % 2,104 3.5 % -18.07%

Managers

Managers TitleAgeSince
Chief Executive Officer 57 14-03-31
Director of Finance/CFO 55 89-12-31
Chief Tech/Sci/R&D Officer 55 20-07-31
Investor Relations Contact - 17-06-30
Investor Relations Contact 50 95-12-31
Corporate Officer/Principal - -
Corporate Officer/Principal - 20-12-31
Corporate Officer/Principal - 14-06-30
Corporate Officer/Principal - 14-03-31
Corporate Officer/Principal - 02-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 63 07-11-26
Director/Board Member 66 15-08-31
Director/Board Member 69 18-02-28
Director/Board Member 71 95-08-31
Director/Board Member 73 03-09-22
Director/Board Member 69 20-05-25
Chief Executive Officer 57 14-03-31
Director/Board Member 65 22-05-23
Director/Board Member 62 21-03-14
Director/Board Member 52 20-03-15

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,578,114,121 2,531,706,123 ( 70.76 %) 1,045,470,249 ( 29.22 %) 70.76 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.665 %
244,776,747 9.665 % 31 123 M $
BlackRock Advisors LLC
6.101 %
154,510,927 6.101 % 19 646 M $
116,865,977 4.614 % 14 860 M $
Wellington Management Co. LLP
3.380 %
85,595,999 3.380 % 10 884 M $
Geode Capital Management LLC
2.189 %
55,428,245 2.189 % 7 048 M $
Fidelity Management & Research Co. LLC
1.688 %
42,749,954 1.688 % 5 436 M $
Merrill Lynch International
1.591 %
40,288,789 1.591 % 5 123 M $
BlackRock Life Ltd.
1.590 %
40,271,751 1.590 % 5 121 M $
Eaton Vance Management
1.585 %
40,129,825 1.585 % 5 103 M $
Charles Schwab Investment Management, Inc.
1.448 %
36,682,866 1.448 % 4 664 M $
NameEquities%Valuation
Caixa DTVM SA
0.001598 %
323,830 0.001598 % 5 M $
BB Gestão de Recursos DTVM SA
0.000789 %
159,900 0.000789 % 3 M $
Safra Asset Management Ltda.
0.000347 %
70,300 0.000347 % 1 M $
Bram Bradesco Asset Management S/A DTVM
0.000255 %
51,684 0.000255 % 825 505 $
XP Allocation Asset Management Ltda.
0.000092 %
18,724 0.000092 % 299 063 $

Holdings

NameEquities%Valuation
13,443,693 10.62% 185,973,865 $
1,739,768 5.21% 23,017,131 $
12,955,016 15.66% 19,691,624 $
1,483,414 5.39% 1,051,741 $
2,297,884 12.13% 827,238 $

Company contact information

Merck & Co., Inc.

126 East Lincoln Avenue

07065, Rahway

+908 740 4000

http://www.merck.com
address Merck & Co., Inc.(MRK)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Pharmaceuticals: Major
Financial Conglomerates
Pharmaceuticals: Major
Merck Holdings, Inc.
Pharmaceuticals: Major
Intervet India Pvt Ltd.
Essex Chemie AG
Miscellaneous Commercial Services

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
121.4 USD
Average target price
134.3 USD
Spread / Average Target
+10.56%
Consensus